UNION CHIMIQUE BELGE
UCB focuses on research and development of medications centered on epilepsy, parkinson's disease, and crohn's disease. Their research and development activities in neurology, immunology, and other areas.
UNION CHIMIQUE BELGE
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1928-01-01
Address:
Brussels, Brussels Hoofdstedelijk Gewest, Belgium
Country:
Belgium
Website Url:
http://www.ucb.com
Total Employee:
5001+
Status:
Active
Contact:
+32 2 559 99 99
Total Funding:
202.21 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Tag Manager Google Maps Content Delivery Network Amazon Font Awesome
Similar Organizations
Bayer
Bayer is a life science company that specializes in the areas of health care and agriculture.
Berlin Chemie
Berlin Chemie is an international pharmaceutical research company specializing the development and distribution of new pharma products.
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Merck
Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Purdue Pharma
Purdue Pharma L.P., a pharmaceutical company committed to improving patients' lives and serving the healthcare community.
Roche France
Roche Diagnostics France is a biotechnology company that focuses on the research and development of pharmaceuticals and diagnostics.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
2019-04-01
Board_member
2021-05-01
Board_member
Board_member
2008-04-24
Board_member
Current Employees Featured
Heresh Rezavandi Ecosystem Strategic Intelligence Lead, Associate Director @ Union Chimique Belge
Ecosystem Strategic Intelligence Lead, Associate Director
William Mandarino Associate Director, Global Regulatory Systems And Technology @ Union Chimique Belge
Associate Director, Global Regulatory Systems And Technology
2000-02-01
Helene Finney Head of Bispecific Target Discovery @ Union Chimique Belge
Head of Bispecific Target Discovery
2019-01-01
Eddie Chan VP & Head, Global Marketing @ Union Chimique Belge
VP & Head, Global Marketing
2016-05-01
Helene Finney Director, Functional Screening @ Union Chimique Belge
Director, Functional Screening
1989-08-01
Jean Tellier Chief Executive Officer & Chairman @ Union Chimique Belge
Chief Executive Officer & Chairman
2015-01-01
Sara Stroo HR Technology Project Lead @ Union Chimique Belge
HR Technology Project Lead
Herman De Prins CIO @ Union Chimique Belge
CIO
2009-10-01
Sidath Katugampola Director Biomarker and Translational Medicine @ Union Chimique Belge
Director Biomarker and Translational Medicine
2018-09-01
Dhaval Patel Executive Vice President and Chief Scientific Officer @ Union Chimique Belge
Executive Vice President and Chief Scientific Officer
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-01-19 | Zogenix | Zogenix acquired by Union Chimique Belge | 1.9 B USD |
| 2020-11-12 | Handl Therapeutics | Handl Therapeutics acquired by Union Chimique Belge | N/A |
| 2020-06-05 | Engage Therapeutics | Engage Therapeutics acquired by Union Chimique Belge | 270 M USD |
| 2019-10-10 | Ra Pharmaceuticals | Ra Pharmaceuticals acquired by Union Chimique Belge | 2.1 B USD |
| 2018-04-05 | Element Genomics | Element Genomics acquired by Union Chimique Belge | 30 M USD |
| 2017-06-06 | Beryllium Discovery | Beryllium Discovery acquired by Union Chimique Belge | N/A |
| 2011-11-22 | Lectus Therapeutics | Lectus Therapeutics acquired by Union Chimique Belge | N/A |
| 2006-09-25 | Schwarz Pharma AG | Schwarz Pharma AG acquired by Union Chimique Belge | 4.4 M EUR |
| 2006-01-01 | Intranasal Therapeutics | Intranasal Therapeutics acquired by Union Chimique Belge | N/A |
| 2004-05-18 | Celltech Therapeutics | Celltech Therapeutics acquired by Union Chimique Belge | N/A |
Investors List
Financière de Tubize SA
Financière de Tubize SA investment in Post-IPO Equity - Union Chimique Belge
Paul Capital
Paul Capital investment in Post-IPO Equity - Union Chimique Belge
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-04-03 | Neurava | Union Chimique Belge investment in Seed Round - Neurava | 2.26 M USD |
| 2024-03-04 | IMIDomics | Union Chimique Belge investment in Corporate Round - IMIDomics | N/A |
| 2022-10-04 | Bingli | Union Chimique Belge investment in Series A - Bingli | 5.4 M EUR |
| 2021-01-13 | Nile AI | Union Chimique Belge investment in Corporate Round - Nile AI | 25 M EUR |
| 2020-07-01 | EYSZ | Union Chimique Belge investment in Seed Round - EYSZ | 1.95 M USD |
| 2019-02-05 | Aetion | Union Chimique Belge investment in Series B - Aetion | 27 M USD |
| 2018-09-25 | Ceribell | Union Chimique Belge investment in Series B - Ceribell | 35 M USD |
| 2018-06-13 | StrideBio | Union Chimique Belge investment in Series A - StrideBio | 15.7 M USD |
| 2015-06-23 | Clementia Pharmaceuticals | Union Chimique Belge investment in Venture Round - Clementia Pharmaceuticals | 60 M USD |
| 2014-08-19 | Dermira | Union Chimique Belge investment in Series C - Dermira | 51 M USD |
Newest Events participated
Participated in BIO-Europe 2017 | November 6–8 in Berlin, Germany
on 2017-11-06 as exhibitor
Participated in Digital Health World Congress 2017
on 2017-05-23 as sponsor
Official Site Inspections
http://www.ucb.com Semrush global rank: 466.97 K Semrush visits lastest month: 73.94 K
- Host name: 20.123.173.188
- IP address: 20.123.173.188
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Union Chimique Belge"
About UCB | UCB
UCB was created in Brussels by Emmanuel Janssen in the 1920s. The company expanded and entered the US market in the 1930s. Our scientists' first therapeutic breakthroughs came in the …See details»
Home | UCB
Join us and make a world of difference as we work together to become the patient-centric biopharma leader, supported by a dynamic team in Canada and abroad.See details»
UCB (company) - Wikipedia
UCB (Union Chimique Belge) is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous systemSee details»
About UCB | UCB
A global biopharma company, focusing on neurology and immunology. Our business is strong. Total revenue grew to €5.3 billion in 2020. We are more than 7,600 people in all four corners …See details»
Our purpose and strategy - reports.ucb.com
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology. We work with the patients and the scientific community to find new treatments, while continuing …See details»
Corporate Governance - UCB
Dec 31, 2023 UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology. We work with the patients and the scientific community to find new treatments, …See details»
Our purpose and strategy - UCB
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology. We work with the patients and the scientific community to find new treatments, while continuing …See details»
United Christian Broadcasters - Wikipedia
United Christian Broadcasters is a Christian media charity that exists to offer opportunities to hear, watch or read the Bible.UCB has two national Christian radio stations (UCB 1 and UCB 2), the …See details»
Org Chart UCB - The Official Board
The org chart of UCB contains its 81 main executives including Jean Christophe Tellier, Sandrine Dufour and Mark Morgan.See details»
Working at UCB | UCB Careers
UCB culture and working environment. We are a purpose driven organization which inspires a culture of inclusion. Our employees work to create value and societal impact now and into the …See details»
Corporate Governance - UCB
UCB SA/NV has adopted the 2020 edition of the Belgian Code of Corporate Governance as its reference Code taking into account the specific international aspects of the Company. As part …See details»
Our Culture and Values | UCB
Our patients rely on us to develop new medicines that will have a major positive impact on the quality of their lives. Innovative science is the foundation of everything we do.See details»
UCB - Crunchbase Company Profile & Funding
UCB conducts clinical trials to test new treatments, focusing on severe diseases. They aim to make trial results accessible and work towards more diverse trial participation. ... UCB, in …See details»
Responsibility | UCB
UCB was ranked among the Global 100 List of the World’s Most Sustainable Companies by the Canadian organization Corporate Knights. UCB is also working globally to reduce its carbon …See details»
How UCB creates value
7 This figure represents the number of roles that are created in UCB within a specific time period and are filled by a candidate following an active recruitment process regardless of the …See details»
Sustainability | UCB
Our areas of focus are based on a thorough materiality assessment exercise with the goal to identify the most relevant environmental, social, and governance topics for UCB, based on …See details»
United Collection Bureau
United Collection Bureau, Inc. (UCB) assists in the accounts receivable process for healthcare facilities, financial services businesses and government entities. We are hiring at all locations. …See details»
UCB at a Glance
1 For calculating 2023 patient numbers, UCB switched to an external source to facilitate auditability. 2023 patient numbers and year-over-year comparisons in this document are …See details»
Funding - UCB
FUNDING. At UCB, we have made a commitment to help patients living with severe diseases to achieve the lives they aspire to. In support of our commitment, UCB supports a variety of …See details»
UCB stakeholders race to meet ₹300 crore capital target by RBI …
1 day ago Key stakeholders racing to meet RBI deadline for UCB umbrella organization's required capital, urging banks to contribute. The umbrella organisation aims to provide crucial …See details»